Home » Featured Articles » ‘We are very much unprepared against yet unknown RNA viruses’

‘We are very much unprepared against yet unknown RNA viruses’

Martijn van Hemert is one of the principal investigators at the Leiden University Medical Center Department of Medical Microbiology and will be speaking at the NCOH Annual Scientific Meeting on 30 May 2018 on the subject of inhibition of chikungunya virus replication. Beforehand we asked him three questions.

What question are you trying to answer with your research?

We aim to understand at the molecular level how pathogenic RNA viruses replicate and interact with the host cell, with the ultimate goal of inhibiting their replication. At the moment the research within my group is mainly focussed on Zika and chikungunya virus, two viruses that are transmitted by mosquitos and that have affected the lives of millions of people around the world over the past decade.

Why is this important?

Many emerging infections and large outbreaks of infectious diseases are caused by (re)emerging RNA viruses that can cause serious disease in humans and livestock. Increasing globalization, changes in human behaviour and climate change will likely only increase problems with the (re)emergence and further spread of viral diseases. At the same time we are very much unprepared against these viruses, as effective antiviral therapy or registered vaccines to treat or prevent infections are still not available for many RNA viruses.

What do you ultimately want to achieve?

The molecules and antiviral strategies that we discover and study in the lab should ultimately lead to the development of antiviral therapy to prevent or cure infections that currently are a large burden to societies and the quality of life of individual patients. For example people suffering from the persistent joint pains caused by chikungunya virus infection. Broad-spectrum antivirals should prepare us for outbreaks of new and yet unknown viruses that will undoubtedly emerge in the future.

More News

Save the date: next NCOH Science Café on 29 October

It’s time for an update! You and all NCOH scientists are invited to join the NCOH Science Café on 29 October 2019 to get up to speed with the latest developments, meet fellow NCOH colleagues, and establish new collaborations. Feel free to inform your fellow researchers and PhD students about the Science Café, they will... More

People themselves are main source of ESBL antibiotic resistance

Researchers from the National Institute for Public Health and the Environment, Utrecht University, University Medical Center Utrecht, the Animal Health Service and Wageningen Bioveterinary Research, all members of the ESBLAT consortium, have previously shown that ESBL antimicrobial resistance is common in humans, livestock and companion animals, food of animal origin and the environment. However, ESBL... More

One Health applications for prophylactic vaccines and preventive strategies – A joint call by Netherlands Centre for One Health and Top Sector Life Sciences & Health

The Netherlands Centre for One Health (NCOH) was allocated a budget of two million euro Public-Private Partnership (PPP) Allowance to organise and realise their first PPP call. This call involves strategic partnerships under the Knowledge and Innovation Agenda of Top Sector Life Sciences & Health (LSH): One Health call.

More

Antimicrobial resistance remains fairly stable in the Netherlands

The number of bacteria that are resistant to antibiotics is increasing globally. In the Netherlands this number remains fairly stable and is lower than in many other countries. Nevertheless, there is still cause for concern and caution. This is evident from the annual report NethMap/MARAN 2019 in which various organisations jointly present data on antibiotic... More